Cargando…
Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China
BACKGROUND: China’s National Free Antiretroviral Treatment Program (NFATP) has substantially increased the survival rate since 2002. However, the emergence of HIV drug resistance (HIVDR) limits the durability and effectiveness of antiretroviral treatment (ART) in at risk patients. METHOD: A cross-se...
Autores principales: | Zuo, Zhongbao, Liang, Shu, Sun, Xianguang, Bussell, Scottie, Yan, Jing, Kan, Wei, Leng, Xuebing, Liao, Lingjie, Ruan, Yuhua, Shao, Yiming, Xing, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172524/ https://www.ncbi.nlm.nih.gov/pubmed/27997554 http://dx.doi.org/10.1371/journal.pone.0166661 |
Ejemplares similares
-
Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
por: Liu, Pengtao, et al.
Publicado: (2018) -
Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
por: Kan, Wei, et al.
Publicado: (2017) -
Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China
por: Liang, Shujia, et al.
Publicado: (2015) -
HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China
por: Leng, Xuebing, et al.
Publicado: (2014) -
HIV drug resistance in patients in China’s national HIV treatment programme who have been on first-line ART for at least 9 months
por: Liu, Pengtao, et al.
Publicado: (2020)